Tuesday, November 5, 2024
Subscribe American Journal of Medicine Free Newsletter
Clinical ResearchIncreased Prevalence of Coronary Artery Disease in Severe Psoriasis and Severe Atopic...

Increased Prevalence of Coronary Artery Disease in Severe Psoriasis and Severe Atopic Dermatitis

48-year-old man with severe psoriasis and calcified coronary lesions on CCTA (left); 57-year-old man with severe lifelong atopic dermatitis and mixed coronary plaque in the LAD on CCTA (middle), and no plaques in the RCA (right). CCTA = cardiac computed tomography angiography; LAD = left anterior descending artery; RCA = right coronary artery.
48-year-old man with severe psoriasis and calcified coronary lesions on CCTA (left); 57-year-old man with severe lifelong atopic dermatitis and mixed coronary plaque in the LAD on CCTA (middle), and no plaques in the RCA (right). CCTA = cardiac computed tomography angiography; LAD = left anterior descending artery; RCA = right coronary artery.

Atopic dermatitis  and psoriasis, a systemic inflammatory disease thought to be linked to a range of comorbidities, are associated with an increased prevalence of coronary artery disease.

Background

Psoriasis and atopic dermatitis (AD) are immuno-inflammatory diseases that can result in lifelong systemic inflammation. Unlike AD, psoriasis has been associated with cardiovascular disease. The aim of this study was to examine the prevalence, severity, and subtype of coronary artery disease (CAD) in psoriasis and AD patients without known cardiovascular disease.

Methods

Consecutively enrolled patients (psoriasis n = 58, AD n = 31) and retrospectively matched controls (n = 33) were examined using cardiac computed tomography angiography (CCTA) and assessed using an 18-segment model of the coronary tree.

Results

The prevalence of a coronary artery calcium score >0 was 29.8% in psoriasis and 45.2% in AD, vs 15.2% in controls (P = .09 and P = .01, respectively). More patients with psoriasis had a coronary artery calcium score ≥100 (psoriasis 19.3%, controls 2.9%; P = .02). CCTA showed the presence of plaques in 38.2% of psoriasis patients and 48.1% of AD patients, vs 21.2% of controls (P = .08 and P = .03, respectively). Psoriasis was associated with an increased prevalence of significant coronary stenosis (stenosis >70%) (psoriasis 14.6%, controls 0%; P = .02) and 3-vessel coronary affection or left main artery disease (psoriasis 20%, controls 3%;P = .02), whereas AD was associated with mild (AD 40.7%, controls 9.1%; P = .005) single-vessel affection.

Conclusions

These findings suggest that psoriasis and AD are associated with an increased prevalence of CAD. Patients with psoriasis have an increased prevalence of severe CAD.

To read this article in its entirety and to view additional images please visit our website.

– Kasper Fjellhaugen Hjuler, MD, Morten Böttcher, MD, PhD, Christian Vestergaard, MD, PhD, DMSc, Mette Deleuran, MD, DMSc, Line Raaby, MD, Hans Erik Bøtker, MD, DMSc, Lars Iversen, MD, PhD, Knud Kragballe, MD, PhD, DMSc

This article originally appeared in the December 2015 issue of The American Journal of Medicine.

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...